Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04088370

Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

Inflammatory responses in response to alcohol have been identified as contributing to the development of alcoholic hepatitis. The inflammatory response including that to LippoPolySaccharide is known to lead to progression of alcoholic liver disease. In addition to the inflammatory response mitochondrial perturbations exist and redox homeostasis is altered in patients with alcoholic hepatitis. Though this is known there have been very few studies targeting mitochondrial function in Peripheral Blood Mononuclear Cells (PBMCs). We plan to collect 50 milliliters of blood from healthy control patients so that we can compare the data to that of patients with alcoholic hepatitis and those who are heavy drinkers without liver disease. In addition to studying mitochondrial function we will investigate cytokine response, as well as fatty acid metabolism, glucose, and insulin measurements

Conditions

Interventions

TypeNameDescription
OTHERBlood DrawBlood Draw Only

Timeline

Start date
2019-10-08
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2019-09-12
Last updated
2025-11-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04088370. Inclusion in this directory is not an endorsement.

Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis (NCT04088370) · Clinical Trials Directory